161 related articles for article (PubMed ID: 34958058)
1. Procalcitonin as a predictor of severity and mortality in a cohort of patients hospitalised with COVID-19.
Ahmed S; Ahmed ZA; Rashid NH; Mansoor M; Siddiqui I; Jafri L
Malays J Pathol; 2021 Dec; 43(3):375-380. PubMed ID: 34958058
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum ferritin for prediction of severity and mortality in COVID-19- A cross sectional study.
Ahmed S; Ansar Ahmed Z; Siddiqui I; Haroon Rashid N; Mansoor M; Jafri L
Ann Med Surg (Lond); 2021 Mar; 63():102163. PubMed ID: 33614024
[TBL] [Abstract][Full Text] [Related]
3. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
[TBL] [Abstract][Full Text] [Related]
4. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19.
Liu ZM; Li JP; Wang SP; Chen DY; Zeng W; Chen SC; Huang YH; Huang JL; Long W; Li M; Gao RF; Guo L; Wu XH
Int J Med Sci; 2020; 17(16):2468-2476. PubMed ID: 33029089
[No Abstract] [Full Text] [Related]
5. [Diagnostic value of serum procalcitonin for infection in the immunocompromised critically ill patients with suspected infection].
Yu X; Ma X; Ai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):477-83. PubMed ID: 26049187
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy.
Sheng X; Yang J; Yu G; Fei Y; Bao H; Yin J; Huang W; Tian Z; Wang N; Ronco C
Blood Purif; 2019; 48(3):262-271. PubMed ID: 31311006
[TBL] [Abstract][Full Text] [Related]
7. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin Has Good Accuracy for Prognosis of Critical Condition and Mortality in COVID-19: A Diagnostic Test Accuracy Systematic Review and Meta-analysis.
Zare ME; Wang Y; Nasir Kansestani A; Almasi A; Zhang J
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):557-569. PubMed ID: 33463126
[TBL] [Abstract][Full Text] [Related]
9. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Significance of Procalcitonin Elevation in Patients over 75 Years Old Admitted for COVID-19 Pneumonia.
Ticinesi A; Nouvenne A; Prati B; Guida L; Parise A; Cerundolo N; Bonaguri C; Aloe R; Guerra A; Meschi T
Mediators Inflamm; 2021; 2021():5593806. PubMed ID: 34326704
[TBL] [Abstract][Full Text] [Related]
11. A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients.
Wang RR; He M; Kang Y
J Clin Lab Anal; 2021 Jun; 35(6):e23805. PubMed ID: 34032326
[TBL] [Abstract][Full Text] [Related]
12. Endocan is useful biomarker of survival and severity in sepsis.
Mihajlovic DM; Lendak DF; Brkic SV; Draskovic BG; Mitic GP; Novakov Mikic AS; Cebovic TN
Microvasc Res; 2014 May; 93():92-7. PubMed ID: 24769132
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
[TBL] [Abstract][Full Text] [Related]
14. [The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].
Ma J; Wang S; Chen D; Duan J; Li C; Li G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):688-93. PubMed ID: 27434557
[TBL] [Abstract][Full Text] [Related]
15. Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan.
Sarfaraz S; Shaikh Q; Saleem SG; Rahim A; Herekar FF; Junejo S; Hussain A
PLoS One; 2021; 16(5):e0251754. PubMed ID: 34043674
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin is a predictor of disseminated intravascular coagulation in patients with fatal COVID-19.
Asoğlu R; Tibilli H; Afşin A; Türkmen S; Barman HA; Asoğlu E
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11953-11959. PubMed ID: 33275269
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital.
Akagi T; Nagata N; Miyazaki H; Harada T; Takeda S; Yoshida Y; Wada K; Fujita M; Watanabe K
BMC Geriatr; 2019 Jan; 19(1):3. PubMed ID: 30616612
[TBL] [Abstract][Full Text] [Related]
18. Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection.
Heer RS; Mandal AK; Kho J; Szawarski P; Csabi P; Grenshaw D; Walker IA; Missouris CG
Ann Clin Biochem; 2021 Sep; 58(5):520-527. PubMed ID: 34018843
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Procalcitonin's Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 Patients.
Patel N; Adams C; Brunetti L; Bargoud C; Teichman AL; Choron RL
J Intensive Care Med; 2022 Nov; 37(11):1486-1492. PubMed ID: 35711161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
